Gene Therapy and The Cure To Cancer: Triggering B-Cell and T-cell White Blood Cell Antibody Production

Review Article

Abstract

Recent advancements in gene therapy, where synthetically engineered artificial viruses impregnate target cell types with DNA specifically designed to trigger alterations and adaptations in cell function and morphology, these are currently redefining how we see the future of the treatment of cancer. Through introducing a novel and original innovative strategy to effectively trigger a select portion of the whole immune system, the white blood cells producing antibodies, into successfully producing the optimum of tumor eliminating antibodies. This theoretical research paper explores the hypothetical treatment highlighting the core mechanisms of action for gene therapy cancer treatment wherein synthetically modified gene-sequences are incorporated to trigger immune system changes. Lymphocyte white blood cells specifically, all being triggered through the synthetic cells to produce cancer targeting and destroying antibodies, without compromising the overall immunological ability of the body to combat latently occurring infections; as the pathogen consuming neutrophils would be unaffected. A portion of the immune system is thus reprogrammed through the gene therapy process to specifically target and eliminate cancerous tumors in the body. This study delves explicitly into the specific biochemical mechanisms of action, therapeutic methods, and potential recovery outcomes of this form of gene therapy treatment based on a cross-referenced data metanalysis.